Correspondence to letter to the editor on “Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study”

Author: Young Eun CHON ¹ ; Dong Yun KIM ; Hong Jae CHON ; Do Young KIM
Author Information

1. Department of Gastroenterology, CHA Bundang Medical Center, CHA University, Seongnam, Korea
Publication Type:Correspondence
From:Clinical and Molecular Hepatology 2025;31(1):e98-e100
CountryRepublic of Korea
Language:English